Bobby Prasad - Global Chief Medical Officer, Abraaj
Professor Bobby Prasad is Global Chief Medical Officer for Abraaj and is based in the Group’s London office.
He is a Gastroenterologist and Interventional Endoscopist by training and has been in clinical practice for over 20 years, having worked in senior roles in the UK and US including on faculty at Yale University. He is a Council Member of the World Economic Forum’s Industry Agenda Council on the Future of the Health Sector, a Fellow of the Royal College of Physicians of London and the American College of Physicians. Bobby is a graduate of the University of Oxford.
Paul Zollinger-Read - Chief Medical Officer, Bupa
In July 2012 Paul joined Bupa as their Global Chief Medical Officer. His role ensures that robust global systems of clinical governance are in place, that Bupa commission and provide services based on the latest clinical evidence and that they provide innovative models of care. Developing clinical relationships is an important part of his role.
Paul studied medicine at Cambridge University and Guy’s hospital, before training as a GP in Oxford. After working with the National Health Service (NHS) Modernisation Agency, he set up and became CEO of one of the first Care Trusts in the country, merging health and adult social care.
Paul went on to be CEO of several PCTs, CEO of NHS Cambridgeshire and CEP of NHS Peterborough.
Paul has also served as Medical Advisor and Primary Care Advisor for the Kings Fund and led the development of Clinical Commissioning Groups for the East and Midlands Strategic Health Authority.
Ting Shih - CEO and Founder, ClickMedix
Ting founded ClickMedix, an award-winning healthcare technology enterprise born out of MIT Media Lab to enable health organisations to serve more patients through its eHealth platform. Her areas of expertise include mHealth solution design, competitive strategy, lean/Six Sigma process improvement and operations management.
She spent five years implementing mobile health programmes across 15 countries in North America, South America, Africa, and Asia to develop financially sustainable health programmes through ClickMedix. The programmes equipped health workers, nurses, pharmacists, and physicians with smartphones to capture patient symptoms information, images, and other related health data to be transmitted to remote specialists who can provide diagnosis and treatment advice.
Murray Stewart - Chief Medical Officer, GlaskoSmithKlien
Murray Stewart is Chief Medical Officer for pharmaceuticals at GSK where he is responsible for the efficacy and safety of GSK pharmaceuticals globally.
Murray joined GSK in 2000 as Associate Director for Clinical Research and Development in the UK and since then has held senior positions in the Cardiovascular and Metabolic therapy area.
Before joining the pharmaceutical industry, Murray worked as a diabetes consultant and senior lecturer and was Consultant Physician/Honorary Senior Lecturer and Head of Clinical Services at the Diabetes Centre, Newcastle upon Tyne in the UK. His research was in lipid metabolism in Type 2 diabetes he did his medical training at Southampton Medical School in the UK and is a Fellow of the Royal College of Physicians.
Richard L. Snyder - Senior Vice President and Chief Medical Officer, Independence Blue Cross
Richard Snyder is the company’s chief clinical spokesperson, and has overall corporate responsibility for medical, quality, pharmacy management, and all clinical policies and programmes.
He leads Independence’s efforts to improve the quality of patient care by transforming primary care delivery to the patient-centred medical home model, which focuses on a team approach to accessible, well-coordinated primary care, and promoting the adoption of the accountable-care model among the provider community.
He is active in a variety of state and professional advisory committees and is a member of the AMA, the Pennsylvania Medical Society, the American Academy of Family Physicians, and the Pennsylvania Academy of Family Physicians.
Dr Snyder is a graduate of Franklin and Marshall College and the Medical College of Pennsylvania. He is board certified by the American Board of Family Medicine.
Thomas L. Fariss - Corporate Medical Director, Kimberly Clark
Thomas L. Fariss is currently Corporate Medical Director at Kimberly-Clark Corporation, responsible for medical affairs and employee health services for the company. Dr Fariss joined Kimberly-Clark in 1994 as Regional Medical Director in Neenah.
Dr Fariss graduated from the College of William and Mary with a Bachelor of Science degree in Chemistry in 1983, and received his medical degree from University of Virginia School of Medicine in 1987. He served his internal medicine internship and residency at Georgetown University Hospital in Washington, DC.
In 1994, Dr Fariss completed his Occupational and Environmental Medicine Residency and Master of Public Health degree at George Washington University in Washington, DC.
He is board certified in Internal Medicine, Preventive Medicine/Occupational Medicine, and is a member of several professional societies.
Dr Fariss is based at Kimberly-Clark’s operating headquarters in Roswell, GA. Special interests include preventive health, fitness, and tennis. He is originally from Roanoke, VA. He and his wife, Margaret, have two children.
Hilary Thomas - Chief Medical Adviser, KPMG
Hilary is KPMG in the UK’s Chief Medical Adviser and a member of the Global Centre of Excellence in Healthcare and Life Sciences. In this role she is involved in redesigning care models and pathways and helping organisations, health ecosystems and life sciences companies to navigate the changing way that the public and other stakeholders interact. Downstream this has implications for organisational strategy and business models. She led KPMG’s global health proposition, Care System Redesign from 2010-2014, working across regional health ecosystems to redesign inter-organisational patient pathways and shift the provision of care to more appropriate settings.
Prior to KPMG Hilary spent 23 years in the NHS including as Professor of Oncology at the University of Surrey, Medical Director of the Royal Surrey County Hospital and Group Medical Director of Care UK plc. She was a member of the Healthcare for London Clinical Advisory Group from 2007-10.
Beth Taylor – Mental Health Leader at PwC
Her thirty year career has seen Beth embrace a number of different professional challenges spanning the disparate worlds of banking, academia, motherhood, professional services and psychotherapy; roughly in that order. The consistent thread running through these worlds is a passion for facilitating people’s growth and development, initially as a consultant and coach and latterly as a psychotherapist in training.
Beth has worked for PwC since 2003 and in January 2016 was asked to take on a new role to develop and lead a firm-wide approach to mental health. She is also in the final stages of training with the Metanoia Institute to become a UKCP accredited psychotherapist and volunteers her clinical services to work with a branch of Mind each week.
Cary Adams - Chief Executive Officer, UICC
Cary Adams has a BSc Honours degree in Economics, Computing and Statistics from the University of Bath, and a Masters degree (with Distinction) in Business Administration. He is a Harvard Business School Alumni having attended the School’s Executive General Management programme and has recently been awarded honorary doctorates in International Relations and Health.
In 2009, Cary moved from the management of international businesses in the banking sector to become CEO of UICC in Geneva. UICC unites the cancer community to reduce the global cancer burden, to promote greater equity, and to integrate cancer control into the world health and development agenda.
Its rapidly increasing membership base of over 1000 organisations in more than 160 countries features the world’s major cancer societies, ministries of health and patient groups and includes influential policy makers, researchers and experts in cancer prevention and control. UICC also boasts more than 55 strategic partners.
Dr Rajgopal - Vice President, Global Medical and Occupational Health, Unilever
Dr Rajgopal is responsible for providing strategy and leadership in comprehensive medical and occupational health services covering more than 165,000 employees worldwide.
He represents Unilever in the Global Business Coalition, the Global Diabetes Forum, has been a Leadership Board member of the Workplace Wellness Alliance of the World Economic Forum and is on the steering committee of the Institute of Health and Productivity Management.
He holds postgraduate qualifications in Preventive Medicine, Public Health, Occupational Medicine and in Health and Hospital Administration and is a Fellow of the Faculty of Occupational Medicine, Royal College of Physicians, and the Faculty of Occupational Medicine, Royal College of Physicians, Ireland.
He has served as Chairman of Medichem, Board member of the ICOH and is an Editorial Board member of the IJOMEH.
He has been honoured by the AIHA with their Distinguished Service Award.
Harry Leider - Chief Medical Officer and a Group Vice President, Walgreens
Harry Leider, MD, MBA has over 25 years experience as a physician executive in a variety of innovative healthcare organisations. As Chief Medical Officer and a Group Vice President of Walgreens, he is responsible for developing enterprise-wide health and wellness services that provide customer value and improve patients’ lives. Prior to joining Walgreens, Dr Leider was Chief Medical Officer and Senior Vice President of Ameritox, a national laboratory that provides medication monitoring services to physicians that treat chronic pain and serious mental illness.
In addition to his extensive background in population health, Dr Leider has broad experience in managed care. He served as Chief Medical Officer at XLHealth, a Population Health company and Medicare health plan that served seniors with chronic illnesses. Previously he was Chief Medical Officer for HealthNet, a hospital-owned managed care organisation and a physician executive at Harvard Pilgrim Health Plan.
Daniel Stein - Chief Medical Officer, Walmart Care Clinics
In this role, Daniel is working to offer affordable, convenient, high-quality clinical care for Walmart customers and associates. He co-founded and helps lead Walmart’s recently launched primary care clinic initiative, the Walmart Care Clinic, as well as other health services initiatives.
Previously, Daniel worked on the health staff of the U.S. Senate Finance Committee on policy involving Medicare and Medicaid. In this capacity, Daniel worked extensively on the Medicare Modernisation Act of 2003, the Medicare prescription drug legislation, and medical malpractice reform.
Daniel returned to the U.S. Senate Finance Committee in 2009 to help formulate healthcare workforce and delivery system reform proposals for Senator Baucus’ comprehensive health reform bill which formed the foundation of the Accountable Care Act. Daniel also worked previously at the Centres for Medicare and Medicaid Services (CMS) where his work focused on Medicare quality and pay-for-performance initiatives.
Cary has also served as Chair of the NCD Alliance, a coalition of around 2,000 organisations working on non-communicable disease.
David Hoke – Senior Director Associate Health and Wellbeing, Walmart
David has spent the last 20+ years working with a variety of organisations focusing on measurably improving the health and wellbeing of the workforce. Since joining Walmart in 2012, David has been responsible for designing and delivering offerings that improve the wellbeing of the Walmart workforce.
This work has included a strong focus on applied behaviour change theory, behavioural science, persuasive technology, habit formation and behavioural insights. Prior to joining Walmart, David served with Yum! Brands where he was responsible for designing and delivering wellbeing programmes both inside and outside the US. His focus has been on engagement and the impact of wellbeing on business performance. David’s career has included work with organisations such as the University of Kentucky, SCANA, Sinai Hospital of Baltimore and DuPont.